Flixene for dialysis access
Flixene incorporates a 3 layer ePTFE design for use in both vascular bypass and AV Access graft applications. The 3 layer construction provides Flixene significantly improved strength over previous Getinge double layer ePTFE grafts. To address a broad number of patient needs, Flixene grafts are offered in a variety of configurations including:
A choice of configuration
Getinge offers an extensive line of straight grafts. Straight grafts are often used for those applications where a bypass is needed and vessel diameter remains a constant from the proximal to the distal anastomosis. This configuration is offered in both graduated wall and standard wall thickness.
A wide selection of tapered grafts is also offered for those clinical applications where flow dynamics need to be altered or when performing a bypass between two different diameter vessels.  Configuration available in both graduated wall and standard wall thickness.
Graduated Wall (GW):
Designed to be thinner at the ends of the graft compared to the standard wall design. The Flixene GW grafts offer a reduced wall thickness at the proximal and distal 8 cm segments of the graft. Getinge's engineers were able to achieve this while ensuring sufficient strength to withstand needle cannulation. 
Standard Wall (SW):
Getinge also offers a full line of standard wall thickness grafts.
Clinical data demonstrates the ability of Flixene to be safely cannulated within 24 to 72 hours, enabling patients to begin dialysis within days rather than weeks. 
Flixene comes equipped with the SLIDER GDS tunneling system. Use of the SLIDER GDS has the potential for reducing trauma, tunnel bleeding, graft sweating, edema, and operative infections. 
Flixene AV Access Graft
ePTFE vascular graft
Check the video to understand how to use Flixene and why it is a reliable solution for AV Access graft applications.
Marketing Sales - Brochures
Learn more about the Flixene AV access graft. Flixene includes a slider GDS system with plastic sheath to facilitate tunneling, minimizes pre-wetting and contamination of the graft. Flixene is shown to be a viable option for early cannulation within 3 days, reducing the need and risks associated with CVCs for patients.
Improve your knowledge with our eLearning and training courses
At Getinge Educational Institute, we have dedicated material for topics related to Intensive Care, Cardiovascular Procedures, Peripheral Vascular Surgery, Thoracic Vascular Surgery, and Arteriovenous Access, Operating Room and Sterile Processing. We can support you with information about current technologies and best practices to boost your performance and productivity.
For more information about our onsite events or remote trainings, you can also contact your local sales & service representative.